Taken together these data suggest that PEG-IGF-I could be a viable treatment option to enhance recovery after stroke via an increase in neuroblasts and outgrowth of neurites, which can offer growth factor support to the peri-infarct tissue. The gene discussed is IGF1; the disease is stroke disorder.